International Clinical Trial: Evaluation of a prospective, non-interventional, multicenter, non-inferiority, real-world study comparing the efficacy of a daily oral antiretroviral regimen with a long-acting cetuximab-riptyline regimen in virologically suppressed HIV-1-infected adults

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119550) titled 'Evaluation of a prospective, non-interventional, multicenter, non-inferiority, real-world study comparing the efficacy of a daily oral antiretroviral regimen with a long-acting cetuximab-riptyline regimen in virologically suppressed HIV-1-infected adults' on Feb. 28.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Beijing Youan Hospital, Capital Medical University

Condition: HIV

Intervention: LA group:NA

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: LA group:150;SOC group:150;

Countries of Recruitment: China

To know...